The purpose of this research is to improve survival and recovery for patients with pneumonia. We understand that being a patient with pneumonia can be very concerning. The doctors and the team associated with this research project are dedicated to giving you the best possible treatments. Patients with pneumonia receive many different treatment options as part of standard care but doctors aren’t always sure which of these treatments are best. All medications used in this research project are already available and used routinely to treat patients with pneumonia. In this project, different aspects of treatment are being evaluated: 1. Choice of antibiotic. All patients who doctors think have pneumonia are given antibiotics, but doctors give different antibiotics. At this site, this project evaluates the following antibiotics: • Ceftriaxone and a macrolide • Piperacillin-tazobactam and a macrolide • Amoxicillin-clavulanate and a macrolide The doctors have chosen to have these options available in the study because all of these options are known or believed to be safe and effective. If you are not in the study, it is very likely that the doctors would have treated you with one of these options. However, it is not known which option is best. The choice of antibiotic evaluates different types of “standard care”. The doctors will be asked to consider whether the above antibiotics are appropriate for your individual medical presentation.

https://hdl.handle.net/10137/12788

Community-acquired Pneumonia, Influenza, COVID-19

Randomised, Embedded, Multifactorial, Adaptive Platform trial for Community Acquired Pneumonia

Interventional/Clinical trials research

Project